Clinical Trials Sponsored by Arete Therapeutics
Total 6364 results
-
Cyclerion TherapeuticsCompletedHealthyUnited States
-
Akebia TherapeuticsCompletedHepatic ImpairmentUnited States
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Akebia TherapeuticsCompleted
-
Akebia TherapeuticsCompletedPharmacokinetics | Drug Interaction PotentiationCanada
-
Corcept TherapeuticsCompletedHealthyUnited Kingdom
-
Intarcia TherapeuticsTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
BioMimetic TherapeuticsCompletedFull Thickness Rotator Cuff TearCanada
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
Placon TherapeuticsUnknownBreast Neoplasms | Prostatic Neoplasms | Pancreatic Neoplasms | Ovarian NeoplasmsUnited States
-
United TherapeuticsCompleted
-
Agile TherapeuticsCompleted
-
BioMimetic TherapeuticsCompletedArthritis | Osteoarthritis | Rheumatoid Arthritis | Degenerative Joint Disease | Congenital DeformityUnited States, Canada
-
Heron TherapeuticsCompleted
-
Akebia TherapeuticsCompleted
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Halozyme TherapeuticsCompleted
-
Akebia TherapeuticsWithdrawnAnemia | Dialysis-Dependent Chronic Kidney DiseaseUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Therapeutics, Inc.Completed
-
Acorda TherapeuticsTerminatedRefractory EpilepsyUnited States
-
Fate TherapeuticsTerminatedMetabolic DisordersUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
Cristal TherapeuticsCompletedCancer | Metastatic Cancer | Solid TumorsNetherlands, Belgium
-
Acorda TherapeuticsCompleted
-
Corcept TherapeuticsCompleted
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, United Kingdom
-
Amicus TherapeuticsTerminated
-
Acorda TherapeuticsTerminated
-
Agile TherapeuticsCompletedOvulation SuppressionUnited States
-
Agile TherapeuticsCompleted
-
Argos TherapeuticsTerminated
-
Entasis TherapeuticsCompleted
-
Mateon TherapeuticsUnknownMyelodysplastic Syndromes | Acute Myelogenous LeukemiaUnited States
-
Corcept TherapeuticsCompleted
-
Centrexion TherapeuticsCompletedMorton's NeuromaUnited States
-
UNION therapeuticsCompleted
-
Dermata TherapeuticsCompleted
-
UNION therapeuticsCompletedAtopic DermatitisCanada
-
Corcept TherapeuticsCompletedHealthy | Drug Interaction PotentiationUnited States
-
Egetis TherapeuticsCompletedChemotherapy Induced Peripheral Neuropathy (CIPN)United States
-
Boston TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Atlantic TherapeuticsCompletedStress Urinary IncontinenceGermany
-
Mersana TherapeuticsCompletedNeoplasm MetastasisUnited States
-
Agile TherapeuticsCompleted
-
Mateon TherapeuticsCompletedNeuroendocrine TumorsUnited States